Adicet Bio, Inc.
ACET
$0.8345
$0.00660.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -42.89% | 1.39% | 9.74% | 4.03% | 6.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.39% | -3.19% | -2.61% | 1.08% | -5.85% |
| Operating Income | 1.39% | 3.19% | 2.61% | -1.08% | 5.85% |
| Income Before Tax | -4.40% | -0.71% | 2.58% | 38.90% | 7.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.40% | -0.71% | 2.58% | 38.90% | 7.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.40% | -0.71% | 2.58% | 38.90% | 7.72% |
| EBIT | 1.39% | 3.19% | 2.61% | -1.08% | 5.85% |
| EBITDA | 1.63% | 3.47% | 2.53% | -1.30% | 6.39% |
| EPS Basic | -3.88% | 12.56% | 53.85% | 71.09% | 56.26% |
| Normalized Basic EPS | -3.88% | 12.56% | 53.86% | 52.60% | 56.26% |
| EPS Diluted | -3.88% | 12.56% | 53.85% | 71.09% | 56.26% |
| Normalized Diluted EPS | -3.88% | 12.56% | 53.86% | 52.60% | 56.26% |
| Average Basic Shares Outstanding | 0.50% | 15.18% | 111.10% | 111.37% | 110.98% |
| Average Diluted Shares Outstanding | 0.50% | 15.18% | 111.10% | 111.37% | 110.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |